PRevalence of Obstructive Sleep apnoEa and Reduction of Promoters in AF

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

343 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to identify how many patients who have atrial fibrillation, also have sleep apnoea. This is important because sleep apnoea can be a trigger to atrial fibrillation and it can be corrected with a simple intervention. Therefore it is important to understand its prevalence (how many patients with atrial fibrillation are affected by it). Also, obesity and sleep disorders are often associated, therefore the evolution of atrial fibrillation is studied in patients who also have obesity and have lost weight compared with patients who did not loose any weight or are not obese. As medications or therapy are not changed, this is an observational study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Atherosclerosis in Atrial Fibrillation

NCT01882114

Atrial Fibrillation Metabolic Syndrome Oxidative Stress +2 more

UNKNOWN

Sleep Apnea and Atrial Fibrillation Recurrence

NCT02906839

Sleep Apnea Syndrome Atrial Fibrillation

COMPLETED NA

Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation

NCT05961865

Atrial Fibrillation Marker of Inflammation Inflammation +1 more

RECRUITING

Atrial Fibrillation in Relationship to Sleep Quality and Plasma Biomarkers

NCT03855540

Atrial Fibrillation

UNKNOWN

Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study.

NCT01161251

Atrial Fibrillation Peripheral Vascular Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation Osa Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Polysomnography

Study of the sleep pattern

Intervention Type DIAGNOSTIC_TEST

Lifestyle counselling

Weight loss counselling

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1 episode of atrial fibrillation in the previous year

* BMI \> o = 27Kg/m2
* AHI \>30 o con 15\<AHI\<30 associated with other symptoms (sleeplessness, uncontrolled hypertension and cerebral events)

Exclusion Criteria

* Ejection Fraction \<50%
* HFpEF not related to atrial fibrillation.
* coronary artery disease
* valvular cardiomyopathy
* patient already in treatment for sleep apnoea
* hyperthyroidism

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No